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SUCCESSFUL CONTROL PROGRAM TO IMPLEMENT THE APPROPRIATE ANTIBIOTIC
PROPHYLAXIS FOR CESAREAN SECTION
Silvia Nunes Szente FONSECA(1), Maria Helena SOFIA(1), Silvana QUINTANA(1), Fernanda dos Santos NOGUEIRA(1) & Anna S. LEVIN(2)
SUMMARY
Objective: Describe implementation of a successful program to reduce doses (cefazolin 2 to 1 g) used for antimicrobial
prophylaxis. Methods: Evaluation of an intervention program to reduce prophylactic antimicrobial doses. The intervention included
weekly staff discussions, automatic dispensation of 1g-vial of cefazolin by the pharmacy unless expressly requested by surgeon
and increase in post-discharge surveillance as a strategy to reassure surgeons of the safety of the reduction. In the pre and post
intervention periods, a prospective study of antimicrobial consumption and surgical site infections were measured. Results: There
were 5,164 and 5,204 deliveries in 2001-2002 and 2003-2004, respectively; 1,524 (29.5%) and 1,363 (26%) were cesarean sections.
There was a 45% decrease in cefazolin vials used on average per cesarean section (2.29 to 1.25). Patients evaluated increased from
16% to 67% and the SSI rates in both periods were 3.34% to 2.42%, respectively. Conclusion: An ample intervention, including
administrative and educational measures, led to high compliance with dose reduction and saved more than US$4,000 in cefazolin,
considered important because government reimbursement in Brazil for cesarean section is $80.
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Major postoperative infectious complications such as endometritis
and surgical site infection are important causes of maternal morbidity10.
Antibiotic prophylaxis is recommended in order to decrease infectious
complications in high risk cesarean sections1,2,26. In 1990,
EHRENKRANZ et al.10 demonstrated that routine timely antibiotic
prophylaxis might be associated with a 70% to 75% reduction of risk
of either endometritis or wound infection in low-risk cesarean sections.
CHELMOW et al.8 confirmed these findings in a meta-analysis
demonstrating that prophylactic antibiotic use in low-risk cesarean
sections was associated with a significant reduction in postoperative
fever and endometritis. More recently, in a cost-analysis study this
same group7 concluded that administration of prophylactic antibiotics
for elective cesarean delivery reduced costs by US$30.66 per case
resulting in cost savings for elective cesarean delivery. Most clinical
guidelines2,9,11,13,23,27 advocate the use of a single dose of 1 to 2 g of
cefazolin right after the clamping of the cord in cesarean deliveries.
Increasing healthcare costs have led (or forced) hospitals and clinics
to review procedures, in order to adjust their budgets. Also, concerns
with antimicrobial resistance have pressured infection control
specialists to decrease antimicrobial usage. There is a variation of
dosage of cefazolin in the randomized controlled trials and both 1 and
2 grams are doses suggested in guidelines. To achieve the aim of the
most cost effectiveness under limited resources, a single dose of 1
gram administered immediately after cord clamping among women
undergoing cesarean section is the most appropriate. Despite the
established evidence on the safety of prophylaxis guidelines in cesarean
sections doctors do not change practices easily and compliance with
single-dose prophylaxis for example has been reported to be only 8 to
22%19,20. Based upon a previously successful experience of
implementation of a protocol involving single 2g dose for prophylaxis12,
we decided to decrease the dosage of prophylactic cefazolin from 2
grams to 1 gram in cesarean sections because less use of antibiotics
could bring considerable savings for our philanthropic institution.
Although well established for years, guidelines on the use of
prophylactic antimicrobial are very often not followed6. In our hospital,
house staff physicians were very concerned that this modification would
increase surgical site infections (SSI) despite published
recommendations supporting the use of 1 gram of cefazolin1,23,27. The
objective of this study was to describe a successful program to reduce
doses and costs of antimicrobial prophylaxis without increasing
cesarean section SSI rates.
METHODS
Mater is a philanthropic hospital for women located in Ribeirão Preto,
Brazil. It runs on a limited budget and cares for low-income women.
Mater is supported in part (40% of expenses) by the Brazilian National
Health System; the majority of expenses are paid by a non-profit
foundation, Maternidade Sinhá Junqueira Foundation. Mater receives
preferentially low-risk patients; high-risk patients are transferred to a
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University-affiliated hospital. Fifty percent of Mater patients earn less
than US$100/month, 20% are illiterate, 52% did not complete eight
years of education, 36% are having their first baby and 18% are teenagers.
Brazil is well known for its high rate of elective cesarean procedures4,5
but in Mater indications for cesarean procedures follow the current
established National and International guidelines21,24 acute fetal distress,
severe preeclampsia and HELLP syndrome, dystocia, congenital
anomalies, malpresentation, two or more previous cesarean sections;
and these indications did not change over the study period. In-hospital
surveillance (IHS) was started in the year 2000; also patients were
encouraged to come back for a check-up in Mater if any abnormality
developed after hospital discharge. The Centers for Disease Control and
Prevention definitions for nosocomial infections were used15.
In 2003, to obtain the evidence-based practice under the limited
resources, as in our hospital, we changed the recommended dosage of
cefazolin used for SSI prevention in cesarean sections from 2 g to 1 g
right after the clamping and cutting of the umbilical cord in all women
undergoing cesarean sections. Before this control program was
implemented, intensive discussions took place in weekly meetings during
two months. These meetings involved chief obstetritians, nurses,
administration staff and infection control personnel. During these
meetings all the strategies, difficulties and cost implications of the new
protocol were discussed. The clinical director, himself an anesthesist,
was present and supported the new policy. It was decided by all, that the
pharmacy would automatically dispense only one 1g-vial of cefazolin
unless expressly requested, in writing by the patient’s surgeon, to do
otherwise, and that any changes would be reported to the infection control
department. In our hospital cefazolin is a restricted drug and is used
only for cesarean section prophylaxis. Adherence to the protocol was
measured by comparing the number of used cefazolin vials starting in
2001 through 2004. We estimated compliance by calculating the average
prophylaxis dose per cesarean section, by dividing the total number of
used 1-gram vials by the number of cesarean sections performed in each
period. The 1g-cefazolin vial costs US$2.50; we calculated the costs
with cefazolin by multiplying the number of vials by this value. No
other modification in the standard procedures besides dosage reduction
was implemented in 2003, and the medical staff did not change. We
compared results from two different periods: January 2001 to December
2002 and January 2003 to December 2004. To assure the staff, especially
the surgeons, that the dose reduction was safe, we also compared SSI
rates diagnosed during the first 30 days after delivery, and reinforced
measures to increase active post-discharge active surveillance. An
outpatient clinic to evaluate infection in patients after discharge was
initiated as part of the intervention measures. Post-discharge surveillance
(PDS) was done scheduling regular patient appointments with nurses
for discharged patients approximately two weeks after delivery, looking
for surgical site infections (SSI) (superficial, deep and endometritis)
and urinary tract infections (UTI). The patients were asked to return if
there were any other problems after this visit.
The costs with cefazolin in both periods were also evaluated. The
study was approved by the Ethics Committee of the Hospital.
RESULTS
The main results can be seen in Table 1. The total number of
deliveries remained stable in both study periods; the proportion of
cesarean sections was significantly reduced from 29.5% in 2001-2 to
26% in 2003-4 (p < 0.001). The number and proportion of contacted
patients by post-discharge surveillance (PDS) however increased
significantly (from 16% to 67%) in 2003-2004 due to an increased
effort of the nursing staff to schedule patients for their return visits
after delivery. SSI rates nevertheless did not change. The rate of
endometritis remained stable in both periods. There were less urinary
tract infections in 2003-2004 although not statistically significant. There
was almost a 50% decline in the annual number of cefazolin vials
purchased (from 3,487 to 1,702 and a lower mean number of cefazolin
vials per cesarean section (2.52 to 1.25), with corresponding savings
of more than US$4,000 with the purchase of cefazolin alone.
DISCUSSION
The implementation of a control program for an appropriate
regimen of antibiotic prophylaxis in cesarean section, as the
recommended in our study, was successful. Before the control program
was launched, comprehensive education and intensive discussion among
the stakeholders were positively responded. Not only the cost of
cefazolin but also the gap of evidence-based practice on antibiotic
prophylaxis in cesarean section was reduced.
Preceding the implementation of the new protocol, extensive
education on the new policy was done allowing ample discussion among
all the staff involved. We also took administrative measures to make
proper prophylaxis practically automatic and required surgeons to
expressly request, in writing, any prescription that did not follow the
protocol. The almost 50% decrease in cefazolin vial use also pleased
the administrators who played a very important role in actively
supporting the policy and making sure that only 1-g cefazolin vials
would be dispensed from pharmacy.
Infection is described as an important complication of surgery and
is a costly complication of cesarean deliveries7,10. Antimicrobial
prophylaxis is one of the preventive strategies used to decrease infectious
complications; on the other hand, inappropriate and indiscriminate use
of prophylactic antibiotics may increase costs through unnecessary drug
Table 1
Total number of deliveries; proportion of cesarean sections;
rates of infection; and number and costs of cephazolin vials purchased
in 2001-2002 and 2003-2004
2001-2002 2003-2004
# Deliveries 5,164 5,204
# C-sections (%) 1,524 (29.5%) 1,363 (26%)
# Contacted patients (%) 808 (16%) 3,487 (67%)
# Total SSI C-sections (%) 51 (3.34%) 33 (2.42%)
# Superficial SSI (%) 26 (1.7%) 21 (1.54%)
# Deep SSI (%) 7 (0.46%) 2 (0.15%)
# C-section endometritis (%) 18 (1.18%) 9 (0.66%)
# C-section UTI (%) 13 (0.85%) 6 (0.44%)
# Cephazolin vials (costs in US$) 3,487 ($8,717) 1,702 ($4,255)
# Cephazolin vials/C-section 2.29 1.25
C-section = cesarean section; SSI = surgical site infection; UTI = urinary tract
infection.
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use. Several guidelines have been published2,26 suggesting that a single
dose of cefazolin right after the clamping of the cord is effective for SSI
prevention but the recommended dosage varies between 1 and 2 grams.
We saw in these recommendations an opportunity to safely decrease
antibiotic usage in our institution by decreasing prophylaxis in cesarean
section from 2 g to 1 g of cefazolin. Costs are an appealing argument for
decreasing antibiotic usage; there are publications in the literature
showing substantial savings with less antibiotic usage3,12,25. Our data
pointed to a yearly decrease in costs of more than US$2,000 considering
only the decrease in the purchase of cefazolin vials. Although this decrease
may be viewed as modest it was considered important because the
Brazilian National Health System reimbursement for a cesarean section
is only US$80.
It is a well known fact that SSI is much more common in cesarean
deliveries than in normal deliveries16,18. HEMSELL13 in a literature
review, showed that low socioeconomic status, young maternal age,
long duration of membrane rupture and preoperative anemia are risk
factors for SSI after cesarean deliveries, and all these are common
features in our population. More recently, KILLIAN et al.17 showed, in
a multivariate analysis of over 700 patients undergoing cesarean
deliveries, demonstrated that the risk of SSI increased 2.58 fold in the
absence of prophylaxis (CI95%, 1.3-5.1). Although there are well
established guidelines for prophylaxis in surgical procedures,
compliance has been reported to be relatively low. In one report
involving different surgical procedures, the moment of starting the
antimicrobial was correct in less than 60%, and discontinuation was
adequate in 41% of the operations6.
The reasons given for non-compliance with guidelines or hospital
recommendations were: the personal experience of the physician;
difficulty or a perceived contamination during the operation; the belief
that multiple doses are superior to one under their local conditions13.
One of the main concerns of our house staff was the possible increase
in the rates of infection in our low-income population. Therefore we
considered it essential to implement surveillance of infectious
complications to assure the staff that the infection rates would not
increase. SSI rates are better determined through post-discharge
surveillance. Most SSIs will occur after the patient is discharged14,22.
In maternity ward where patient length of stay is always very short it
is probable that almost all infectious complications will go undetected17
unless a post-discharge surveillance system is implemented. We
implemented such a system, and we increased the proportion of
contacted patients from 16% to 67% from 2001-2002 to 2003-2004.
To our surprise, the SSI rates in 2003-2004 did not increase. For the
house staff, these data were very reassuring.
Our study has limitations. First, we performed an observational
study in which there was no simultaneous control group. We did not
evaluate each patient submitted to a cesarean delivery to assess if both
groups of patients were comparable. Because no substantial
modification of the general patient population (low-income and low
risk young patients) occurred from 2001 to 2004, and because of the
large number of patients studied, we believe that no such bias occurred.
Second, no attempt was made to assess if prophylaxis was correctly
given right after cord clamping. It is our understanding that it is very
important to assess and ensure correct timing. Another limitation is
that each patient could not be evaluated individually as to compliance
to the new dose. However we feel that compliance could be adequately
estimated based on average consumption of cefazolin per cesarean
section, as this drug was restricted and used only for this indication.
We believe that it is a difficult task to achieve compliance with
surgical prophylaxis protocols. To succeed it is necessary to implement
educational and administrative measures and to deal with the beliefs
of the surgeons concerning safety for the patients.
RESUMO
Sucesso de um programa para a implantação de profilaxia
antimicrobiana apropriada em cesárea
Objetivo: descrever a implantação de um programa de redução de
doses usadas para profilaxia antimicrobiana em cesárea. Métodos:
Descrição a implantação de um programa de redução de profilaxia
com cefazolina de 2 g para 1 g através de discussões semanais com
profissionais, dispensação automática de frascos de 1 g de cefazolina
pela farmácia exceto quando feito pedido expresso pelo cirurgião.
Houve um trabalho para aumentar a vigilância pós alta, com o objetivo
de tranquilizar os cirurgiões quanto à segurança da nova dose. Foi
realizada uma avaliação prospectiva, antes e depois da implantação do
programa, do consumo de cefazolina e das taxas de infecção obtidas
por vigilância durante a hospitalização e após a alta. Resultados: Houve
5.164 e 5.204 partos em 2001-2 e 2003-4, respectivamente, sendo que
1.524 (29,5%) e 1.363 (26%) foram cesáreas. Houve uma queda de
consumo de frascos de cefazolina de 45% (2,29 para 1,25 por cesárea).
O número de pacientes avaliados para infecção hospitalar aumentou
de 16% para 67%, e as taxas de infecção foram 3,34% e 2,42%,
respectivamente. Conclusão: Uma intervenção ampla, que incluiu
medidas administrativas e educacionais, levou a uma alta adesão ao
programa de redução de dose profilática em cesárea e permitiu uma
economia acima de US$ 4.000 apenas considerando custos com
cefazolina. Esta pode ser considerada importante especialmente porque
o reembolso do SUS para parto cesárea é aproximadamente US$ 80.
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